0001415889-24-011199.txt : 20240419 0001415889-24-011199.hdr.sgml : 20240419 20240419094506 ACCESSION NUMBER: 0001415889-24-011199 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240417 FILED AS OF DATE: 20240419 DATE AS OF CHANGE: 20240419 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gibney Anthony S CENTRAL INDEX KEY: 0001750132 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37783 FILM NUMBER: 24856028 MAIL ADDRESS: STREET 1: C/O ACHILLION PHARMACEUTICALS, INC. STREET 2: 300 GEORGE STREET CITY: NEW HAVEN STATE: CT ZIP: 06511 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Clearside Biomedical, Inc. CENTRAL INDEX KEY: 0001539029 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 452437375 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 900 NORTH POINT PARKWAY STREET 2: SUITE 200 CITY: ALPHARETTA STATE: GA ZIP: 30005 BUSINESS PHONE: 678-270-3631 MAIL ADDRESS: STREET 1: 900 NORTH POINT PARKWAY STREET 2: SUITE 200 CITY: ALPHARETTA STATE: GA ZIP: 30005 4 1 form4-04192024_010400.xml X0508 4 2024-04-17 0001539029 Clearside Biomedical, Inc. CLSD 0001750132 Gibney Anthony S C/O CLEARSIDE BIOMEDICAL, INC. 900 NORTH POINT PARKWAY, SUITE 200 ALPHARETTA GA 30005 true false false false 0 Common Stock 2024-04-17 4 P 0 6710 1.25 A 6710 D Common Stock 2024-04-18 4 P 0 93290 1.30 A 100000 D The reported price in Column 4 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $1.249 to $1.38 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. /s/ Mark Ballantyne, Attorney-in-Fact 2024-04-19